指南与共识神经儿科影像MRCT

中枢神经系统生殖细胞肿瘤的影像学疗效评估:欧洲儿科肿瘤学会脑肿瘤组与北美儿童肿瘤协作组的共识建议

Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group.
指南 / 共识 · Lancet Oncol · 2022-01-01

欧洲儿科肿瘤学会脑肿瘤组与北美儿童肿瘤协作组成立国际工作组,回顾现有文献与当前实践,针对中枢神经系统生殖细胞肿瘤最常见的部位及局部区域延伸的定义,制定影像学疗效评估的共识建议与新临床影像标准,以使疗效评估更一致并促进国际研究间治疗结果的直接比较。

要点

  • 新共识定义了中枢神经系统生殖细胞肿瘤最常见部位的影像学评估标准。
  • 共识明确了局部区域延伸的影像学定义。
  • 统一标准旨在使国际研究间的疗效评估与治疗结果可直接比较。

核心结论

  • 新临床影像标准将允许中枢神经系统生殖细胞肿瘤患者的治疗反应评估更加一致,并促进国际研究之间治疗结果的直接比较。

研究设计与样本

  • 欧洲儿科肿瘤学会脑肿瘤组与北美儿童肿瘤协作组成立国际工作组,回顾现有文献与当前实践、识别影像评估的主要挑战并制定共识建议。

诊断标准与关键数值

  • 针对中枢神经系统生殖细胞肿瘤最常见部位及局部区域延伸的定义,制定了新的临床影像标准。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Homogeneous and common objective disease assessments and standardised response criteria are important for better international clinical trials for CNS germ cell tumours. Currently, European protocols differ from those of North America (the USA and Canada) in terms of criteria to assess radiological disease response. An international working group of the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group was therefore established to review existing literature and current practices, identify major challenges regarding imaging assessment, and develop consensus recommendations for imaging response assessment for patients with CNS germ cell tumours. New clinical imaging standards were defined for the most common sites of CNS germ cell tumour and for the definition of locoregional extension. These new standards will allow the evaluation of response to therapy in patients with CNS germ cell tumours to be more consistent, and facilitate direct comparison of treatment outcomes across international studies.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Morana G, Shaw D, MacDonald SM, et al. Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group. Lancet Oncol. 2022. PMID: 35489353. doi:10.1016/S1470-2045(22)00063-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。